🇪🇺 Retaane in European Union

EMA authorised Retaane on 31 December 2009

Marketing authorisation

EMA — authorised 31 December 2009

  • Application: EMEA/H/C/000635
  • Marketing authorisation holder: Alcon Laboratories (U.K.) Limited.
  • Local brand name: Retaane
  • Status: withdrawn

Read official source →

Retaane in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Ophthalmology approved in European Union

Frequently asked questions

Is Retaane approved in European Union?

Yes. EMA authorised it on 31 December 2009.

Who is the marketing authorisation holder for Retaane in European Union?

Alcon Laboratories (U.K.) Limited. holds the EU marketing authorisation.